EPotentia

22/05/2026

The future of artificial intelligence is not just about algorithms. It is about the physical hardware that runs them. 🇪🇺📈

A recent article by Bruegel points out that Europe is currently lagging behind the US and China in the race for AI compute power. Without a strategy to build its own advanced chip industry, Europe risks becoming entirely dependent on foreign technology for the most critical tool of the 21st century.

The authors suggest that Europe needs to follow a model similar to how Airbus was created by pooling resources, focusing on existing strengths like ASML's technology, and using coordinated public procurement to support domestic hardware. It is a long term challenge, but absolutely essential for maintaining European economic autonomy.

https://www.bruegel.org/analysis/europe-needs-strategy-close-artificial-intelligence-compute-gap

18/05/2026

Deep space exploration has a major computing bottleneck. Current space processors are built to survive extreme radiation, but they lack the processing power needed for advanced artificial intelligence. NASA is working to change that. 🚀

The agency just began testing a new radiation hardened space chip that delivers up to 500 times the performance of current models. By bringing massive computing power and onboard AI to deep space, future spacecraft will be able to make real time decisions without waiting for remote instructions from Earth. This is a massive engineering win for future missions to the Moon, Mars, and beyond! 🌌💻

https://www.sciencedaily.com/releases/2026/05/260515002134.htm

13/05/2026

Artificial intelligence has the potential to completely transform drug discovery, but the models are starving for high quality training data.

To fix this bottleneck, researchers at the University of Oxford and the OpenBind consortium have officially released a massive open dataset and predictive AI model for the global scientific community. The release includes detailed X-ray images and binding measurements for hundreds of compounds, providing the exact kind of industrial scale experimental data that models need to make reliable predictions.

By open sourcing this data, OpenBind is helping researchers worldwide streamline the slow and costly process of designing new life saving medicines. 🧬💻

https://www.ox.ac.uk/news/2026-05-12-openbind-releases-first-open-dataset-and-ai-model-for-drug-discovery

12/05/2026

Bringing a new drug to market takes nearly a decade and costs over $2 billion, yet up to 90% of compounds fail in clinical trials. The pharmaceutical industry desperately needs a way to de-risk this process, and artificial intelligence is providing the answer. 🧬

A new article from The Scientist explores the rise of AI in Companion Diagnostics. Instead of relying entirely on traditional pathology which can be highly variable across different global labs, researchers are using AI to analyze whole slide images and extract quantitative biomarkers. These AI tools act as a "second set of eyes," helping scientists stratify patients more effectively and detect early efficacy signals long before traditional clinical endpoints mature.

While AI will never replace human pathologists, it is automating the most repetitive, time consuming tasks so doctors can focus on complex diagnostic synthesis. This is exactly how technology will accelerate the future of precision medicine! 🩺💻

https://www.the-scientist.com/how-ai-is-de-risking-drug-development-and-companion-diagnostics-74456?utm_source=chatgpt.com

01/05/2026

Pancreatic cancer is notoriously difficult to treat because it rarely shows signs until the disease has already spread. Over 85% of patients receive a diagnosis too late. But a new artificial intelligence model from Mayo Clinic could change those odds completely.

Researchers developed an AI system called REDMOD that analyzes routine abdominal CT scans to detect subtle pre-tumor tissue changes. In a landmark validation study, the AI identified pancreatic cancer up to three years before doctors made a clinical diagnosis! At the two year mark, it caught nearly three times as many cases as specialists looking at the exact same scans.

The system is now moving into clinical testing. This is exactly how machine learning will revolutionize preventative healthcare and save lives. 🩺💻

https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-ai-detects-pancreatic-cancer-up-to-3-years-before-diagnosis-in-landmark-validation-study/

30/04/2026

For decades, clinical trial data has been delayed by a slow, step-by-step reporting process that can add years to drug development. But the FDA is looking to change that with modern technology. 🏥

The agency just announced major steps to implement Real-Time Clinical Trials. By utilizing advancements in AI and data science, the FDA aims to monitor trial safety signals and endpoints in real time as they actually happen. Proof-of-concept trials are already running with AstraZeneca and Amgen.

If successful, this AI-driven continuous monitoring could eliminate the long waiting periods between trial phases and get life-saving therapies to patients significantly faster! 💊💻

The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT).

23/04/2026

The administrative burden on doctors and nurses is staggering, but AI is finally stepping in to help. 🏥

OpenAI has officially launched ChatGPT for Clinicians, offering free access to verified U.S. medical professionals. This specialized version is designed to handle time-consuming tasks like documentation, referral letters, and deep medical research. It features trusted citations from peer-reviewed journals and optional HIPAA compliance.

By taking the administrative weight off healthcare workers, specialized tools like this could give doctors significantly more time to focus on actual patient care. A fantastic example of AI solving real-world workflow problems! 🩺💻

OpenAI makes ChatGPT for Clinicians free for verified U.S. physicians, nurse practitioners, and pharmacists, supporting clinical care, documentation, and research.

22/04/2026

Scientific AI plays by completely different rules than consumer tech, and our security strategies need to reflect that reality. 🇪🇺💻

In our latest article at Epotentia, we dive into the unique challenges of deploying AI for science and industry. A hallucination in a consumer chatbot is just a glitch, but in materials science or biotech, it can waste months of vital research.

We also look at why current regulatory filters are holding back legitimate scientists. Instead of relying on flawed individual model restrictions, we propose that the EU builds a shared "AI Security Commons" to act as a universal firewall for all European deployments.

Check out our full analysis and recommendations for the European Commission’s Expert Forum on Frontier AI!

https://www.epotentia.com/gaps-in-europes-frontier-ai-strategy/

21/04/2026

Predicting chaos—like weather patterns, turbulent aerodynamics, or blood flow—is incredibly difficult. Full simulations take weeks, while standard AI models lose accuracy over time. 🌪️

Researchers at UCL have found a massive breakthrough by pairing artificial intelligence with quantum computing. Instead of relying solely on one or the other, they used a quantum computer to identify core statistical patterns in the data, then fed that information to a standard AI model.

This "quantum-informed" approach boosted prediction accuracy by 20% and used hundreds of times less memory! It's a highly practical way to achieve a "quantum advantage" today, bypassing the hardware limitations that usually slow quantum research down. 💻⚛️

https://www.sciencedaily.com/releases/2026/04/260417224455.htm

17/04/2026

What happens when an AI becomes the lead scientist? 🔬

Forbes recently explored the fascinating rise of "self-driving labs" (SDLs). Instead of just helping humans analyze data, these closed-loop systems use AI to generate hypotheses, operate robotic lab equipment, and run physical experiments entirely on their own!

Early studies show this automated approach can reduce the number of required experiments by up to 30-fold, radically accelerating discoveries in medicine and materials science. But it also raises massive questions about safety and governance. Ultimately, the future of discovery won't be human vs. machine—it will be humans setting the ethical guardrails and strategy while SDLs handle the physical experimentation. 💻🧪

https://www.forbes.com/sites/bernardmarr/2026/04/17/ai-is-becoming-a-scientist-how-self-driving-labs-will-accelerate-discovery/